Max Franklin

Max Franklin is a seasoned professional in partnership strategy and operations, currently serving as Senior Director at RxVantage since August 2024. Previously, Max held senior leadership roles at Navigating Cancer, where responsibilities included overseeing client success for the Pharma business and developing scalable operational processes. Max's earlier experience includes positions at Quid, focusing on healthcare business intelligence, and at ZS Associates, where extensive market research contributed to strategic decisions for a significant oncology franchise. Max began a career at Freestone Capital Management, analyzing alternative investments. Max holds a BSBA in Finance, Accounting, and Philosophy from Washington University in St. Louis - Olin Business School.